Sei Investments Company Has Trimmed Holding in Merit Med Sys (MMSI) by $406,896; Mitchell Capital Management Co Cut Ormat Technologies (ORA) Position by $373,259

January 16, 2018 - By Richard Conner

Mitchell Capital Management Co decreased its stake in Ormat Technologies Inc (ORA) by 5.46% based on its latest 2017Q3 regulatory filing with the SEC. Mitchell Capital Management Co sold 6,119 shares as the company’s stock rose 0.69% with the market. The institutional investor held 105,911 shares of the public utilities company at the end of 2017Q3, valued at $6.47M, down from 112,030 at the end of the previous reported quarter. Mitchell Capital Management Co who had been investing in Ormat Technologies Inc for a number of months, seems to be less bullish one the $3.32B market cap company. The stock decreased 0.74% or $0.49 during the last trading session, reaching $65.58. About 188,349 shares traded or 18.03% up from the average. Ormat Technologies, Inc. (NYSE:ORA) has risen 34.71% since January 16, 2017 and is uptrending. It has outperformed by 18.01% the S&P500.

Sei Investments Company decreased its stake in Merit Med Sys Inc (MMSI) by 5.25% based on its latest 2017Q3 regulatory filing with the SEC. Sei Investments Company sold 9,688 shares as the company’s stock rose 18.76% with the market. The institutional investor held 174,926 shares of the health care company at the end of 2017Q3, valued at $7.41M, down from 184,614 at the end of the previous reported quarter. Sei Investments Company who had been investing in Merit Med Sys Inc for a number of months, seems to be less bullish one the $2.29 billion market cap company. The stock increased 0.55% or $0.25 during the last trading session, reaching $45.55. About 308,129 shares traded. Merit Medical Systems, Inc. (NASDAQ:MMSI) has risen 81.84% since January 16, 2017 and is uptrending. It has outperformed by 65.14% the S&P500.

Sei Investments Company, which manages about $28.13B US Long portfolio, upped its stake in Arch Cap Group Ltd (NASDAQ:ACGL) by 13,487 shares to 139,035 shares, valued at $13.70 million in 2017Q3, according to the filing. It also increased its holding in Cardinal Health Inc (NYSE:CAH) by 61,860 shares in the quarter, for a total of 267,730 shares, and has risen its stake in Spx Corp (SPW).

Analysts await Merit Medical Systems, Inc. (NASDAQ:MMSI) to report earnings on February, 20. They expect $0.32 EPS, up 3.23% or $0.01 from last year’s $0.31 per share. MMSI’s profit will be $16.07 million for 35.59 P/E if the $0.32 EPS becomes a reality. After $0.32 actual EPS reported by Merit Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Investors sentiment decreased to 1.28 in 2017 Q3. Its down 0.21, from 1.49 in 2017Q2. It turned negative, as 14 investors sold MMSI shares while 71 reduced holdings. 44 funds opened positions while 65 raised stakes. 44.33 million shares or 0.69% more from 44.02 million shares in 2017Q2 were reported. Altrinsic Advisors Ltd Liability Corporation reported 140,000 shares. Victory Mngmt Inc accumulated 6,955 shares. Moreover, Thrivent For Lutherans has 0% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 30,585 shares. Connecticut-based Columbus Circle has invested 0.13% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Highbridge Ltd holds 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 5,624 shares. Ameritas Inv Prtnrs Inc has invested 0.01% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). Nuveen Asset Mgmt Limited Com holds 0.01% or 26,485 shares in its portfolio. Parkside Commercial Bank reported 0% stake. Legal And General Gru Public Limited Company has invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Guggenheim Cap Ltd Llc stated it has 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). 110,365 are held by Amer Century Companies. First Tru Advisors Limited Partnership has 0.01% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI). Stevens Capital Lp has invested 0.02% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). 1.33M are held by Ameriprise. Nationwide Fund reported 94,612 shares.

Among 8 analysts covering Merit Medical (NASDAQ:MMSI), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical had 18 analyst reports since October 23, 2015 according to SRatingsIntel. On Thursday, November 16 the stock rating was maintained by SunTrust with “Buy”. The firm has “Outperform” rating given on Monday, August 28 by Raymond James. The firm has “Buy” rating by Canaccord Genuity given on Thursday, November 16. The stock has “Outperform” rating by Barrington Research on Monday, October 26. The firm has “Buy” rating by Bank of America given on Thursday, July 20. The firm earned “Buy” rating on Sunday, October 8 by Canaccord Genuity. The firm has “Buy” rating by Canaccord Genuity given on Tuesday, January 2. The rating was initiated by Canaccord Genuity with “Buy” on Tuesday, July 19. The stock has “Buy” rating by Canaccord Genuity on Thursday, July 27. On Thursday, October 26 the stock rating was maintained by Canaccord Genuity with “Buy”.

Since August 3, 2017, it had 0 buys, and 6 selling transactions for $1.99 million activity. The insider ANDERSON A SCOTT sold $1.03 million. 3,106 Merit Medical Systems, Inc. (NASDAQ:MMSI) shares with value of $127,389 were sold by Millner F. Ann.

Among 8 analysts covering Ormat Technologies Inc (NYSE:ORA), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Ormat Technologies Inc had 17 analyst reports since January 4, 2016 according to SRatingsIntel. On Monday, October 23 the stock rating was maintained by Cowen & Co with “Buy”. The stock has “Buy” rating by Roth Capital on Monday, November 13. Cowen & Co maintained it with “Buy” rating and $6700 target in Monday, July 17 report. The stock of Ormat Technologies, Inc. (NYSE:ORA) earned “Mkt Outperform” rating by Avondale on Monday, December 19. JP Morgan downgraded Ormat Technologies, Inc. (NYSE:ORA) rating on Friday, May 6. JP Morgan has “Neutral” rating and $43 target. Oppenheimer maintained the stock with “Buy” rating in Thursday, August 3 report. On Thursday, June 1 the stock rating was maintained by Oppenheimer with “Buy”. The stock has “Equal-Weight” rating by Barclays Capital on Friday, May 26. The firm has “Overweight” rating by JP Morgan given on Wednesday, June 7. The stock has “Buy” rating by J.P. Morgan on Wednesday, June 7.

Investors sentiment decreased to 1.1 in Q3 2017. Its down 0.20, from 1.3 in 2017Q2. It dived, as 16 investors sold ORA shares while 52 reduced holdings. 18 funds opened positions while 57 raised stakes. 20.98 million shares or 1.96% more from 20.58 million shares in 2017Q2 were reported. Impax Asset Management Ltd has invested 1.13% in Ormat Technologies, Inc. (NYSE:ORA). 6,728 are held by Asset Mgmt Inc. Mcf Advisors Ltd Company, a Kentucky-based fund reported 200 shares. Blackrock Incorporated holds 2.48 million shares. Guinness Asset Ltd reported 0.08% in Ormat Technologies, Inc. (NYSE:ORA). First Mercantile Trust Communications holds 0.09% or 8,266 shares in its portfolio. Ubs Asset Americas stated it has 0% of its portfolio in Ormat Technologies, Inc. (NYSE:ORA). Tru Com Of Vermont invested 0.01% in Ormat Technologies, Inc. (NYSE:ORA). Invesco Ltd holds 0.01% or 386,355 shares in its portfolio. Moreover, Trillium Asset Mngmt Limited Liability Corp has 0.58% invested in Ormat Technologies, Inc. (NYSE:ORA) for 166,903 shares. Guinness Atkinson Asset invested in 5,659 shares. Oppenheimer Asset Mngmt has 0% invested in Ormat Technologies, Inc. (NYSE:ORA) for 1,146 shares. Asset Management reported 5,941 shares. Lpl Limited Liability Corporation has invested 0% in Ormat Technologies, Inc. (NYSE:ORA). Vanguard Grp Incorporated holds 0.01% or 3.13 million shares in its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com